Bernd Schmidt
Technik-/Wissenschafts-/F&E-Leiter bei SENSORION
Aktive Positionen von Bernd Schmidt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SENSORION | Technik-/Wissenschafts-/F&E-Leiter | 11.12.2023 | - |
Karriereverlauf von Bernd Schmidt
Ehemalige bekannte Positionen von Bernd Schmidt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Ausbildung von Bernd Schmidt
Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Statistik
International
Deutschland | 2 |
Vereinigtes Königreich | 2 |
Frankreich | 2 |
Operativ
Graduate Degree | 1 |
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SENSORION | Health Technology |
Private Unternehmen | 1 |
---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Bernd Schmidt
- Erfahrung